EZR and pancreatic neoplasm: Ezrin could be considered as a biomarker for the progression of cervical lesions. In pancreatic cancer cell lines, Ezrin silencing decreased cellular protrusions/microvilli formation, anchorage-independent growth, cell migration and invasion.